Acadia Pharmaceuticals Inc
ACAD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070494
In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 354 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Acadia Pharmaceuticals Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 246 | 223 | −23 |
| Shares | 150.9M | 152.4M | +1.52M (+1.0%) |
| Value | $2.13B | $2.49B | +$366.6M (+17.2%) |
New holders (23)
Institutions that held Acadia Pharmaceuticals Inc at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (46)
Institutions that held Acadia Pharmaceuticals Inc at the end of Q2 2022 and filed for Q3 2022 without it.